FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

IRBESARTAN

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberIRBESARTAN, Tablet, 150 mg has the following codes Pedigree: W003649, EXP: 6/25/2014; Pedigree: AD73686_7, EXP: 5/31/2014.
Where it was soldRepacked drugs were distributed in Arizona, California, Oregon, and Washington.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Labeling:Label Mixup; IRBESARTAN, Tablet, 150 mg may be potentially mislabeled as ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg, NDC 00378041501, Pedigree: W003597, EXP: 6/24/2014; CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: AD76686_7, EXP: 5/31/2014.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Distributed by / forAidaPak Service, LLC
NDC65862063830
Show the full FDA record
Full product labelIRBESARTAN, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65862063830
Recalling firmAidapak Services, LLC
DistributionRepacked drugs were distributed in Arizona, California, Oregon, and Washington.
Quantity60 Tablets
Recall initiated2013-07-02
Report date2014-01-22
Recall completed2014-02-07
Recall numberD-717-2014
ClassificationClass II
FDA statusTerminated
Origin on fileVancouver WA United States

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.